Constructed wetlands with light expanded clay aggregates for agricultural wastewater treatment.

Constructed wetlands (CWs) are receiving a renewed attention as a viable phytotechnology for treating agricultural wastewaters and for the removal of more specific pollutants, in particular recalcitrant ones. In this work, the performance of CW mesocosms using light expanded clay aggregates (LECA) as the bed's substrate and planted with Phragmites australis was investigated for treatment of olive mill wastewater (OMW), swine wastewater (SW) contaminated with oxytetracycline and water contaminated with herbicide MCPA (2-methyl-4-chlorophenoxyacetic acid). Both wastewaters (OMW and SW) initially presented high organic matter content and total suspended solids which were removed by the system with efficiencies higher than 80%. Removal of polyphenols in OMW and nitrogen compounds in SW also showed similar or higher efficiencies in comparison with other treatment systems reported in the literature. The antibiotic oxytetracycline was completely removed from SW within the assay period in unplanted LECA beds, but planted beds allowed a significantly faster removal. In regard to water contaminated with MCPA, the results showed that LECA has a large sorption capacity for this herbicide (removal efficiencies of 56-97%). In general, considerably higher pollutant removal efficiencies were obtained when plants were used (up to 28% higher). The results obtained are indicative that CWs with LECA as substrate may be an adequate option for agricultural wastewater treatment.

Organic xenobiotics removal in constructed wetlands, with emphasis on the importance of the support matrix.

Constructed wetlands (CWs) are increasingly popular as an efficient and economical alternative to conventional wastewater treatment processes for removal, among other pollutants, of organic xenobiotics. In CWs, pollutants are removed through the concerted action of their components, whose contribution can be maximized by careful selection of those components. Specifically for non-biodegradable organic pollutants, the materials used as support matrix of CWs can play a major role through sorption phenomena. In this review the role played by such materials in CWs is examined with special focus on the amount of research that has been conducted to date on their sorption properties relatively to organic compounds. Where available, the reports on the utilization of some of those materials on pilot or full-scale CWs are also recognized. Greatest interest has been directed to cheaper and widely available materials. Among these, clays are generally regarded as efficient sorbents, but materials originated from agricultural wastes have also gained recent popularity. Most available studies are lab-scale batch sorption experiments, whereas assays performed in full-scale CWs are still scarce. However, the available lab-scale data points to an interesting potential of many of these materials for experimentation as support matrix of CWs targeted for organic xenobiotics removal.

Efeito da Lecitina de Soja sobre os Lipídeos e Proteína C reativa e na prevenção da Hipertrofia Ventricular Esquerda de Camundongos Hiperlipidêmicos / Effect of soy lecithin on lipids and C-reactive protein and the prevention of Left Ventricular Hypertrophy in hyperlipidemic mice

A regulação do metabolismo lipídico com drogas ou alimentos naturais é um alvo importante para diminuir o risco de doenças cardiovasculares. O objetivo deste estudo foi verificar o efeito da lecitina de soja na dislipidemia e na hipertrofia ventricular de camundongos hipercolesterolêmicos. Utilizaram-se quatro grupos de camundongos LDLr-/- com 3 meses de idade que receberam a seguintes dietas: Grupo S- ração padrão; Grupo S+Lec- ração padrão e lecitina de soja; Grupo HL- ração hiperlipídica; e Grupo HL+Lec- ração hiperlipídica e lecitina de soja. Após 15 dias, o sangue foi coletado para análise sérica dos lipídeos e da proteína C reativa. O ventrículo esquerdo foi separado, a proporção peso ventricular (mg) pelo peso do animal (g) foi calculada e, em seguida, processado histologicamente. Cortes histológicos foram corados com hematoxilina/eosina e picrosírius red para avaliar alterações morfológicas e morfométricas ventriculares. A lecitina de soja apresentou efeito antidislipidêmico e aumentou os níveis séricos de HDL nos camundongos do grupo S+Lec. Entretanto, nos camundongos do grupo HL+lec, a lecitina de soja não preveniu a dislipidemia, apenas aumentou o nível sérico do HDL. Este efeito nestes animais influenciou no processo inflamatório cardiovascular, reduzindo o nível sérico de proteína C reativa; e prevenindo a hipertrofia ventricular esquerda. A utilização da lecitina de soja representa um tratamento e/ou uma prevenção alternativa de baixo custo para as dislipidemias não associadas com dieta hiperlipídica. Contudo, a lecitina de soja aumenta os níveis séricos do HDL prevenindo o desenvolvimento da HVE mesmo em dislipidemias associadas com dieta hiperlipídica.

The regulation of lipid metabolism with drugs or natural foods is an important target for reducing the risk of cardiovascular disease. The aim of this study was to investigate the effects of soy lecithin on left ventricular hypertrophy (LVH) and dyslipidemia in hypercholesterolemic mice. We used four experimental groups of LDLr-/- mice (aged 3 months), which received the following diets: Group S: standard diet, Group S+Lec: standard diet and soy lecithin; Group HL: hyperlipidic diet and Group HL+Lec: hyperlipidic diet and soy lecithin. After 15 days on these diets, blood was collected for analysis of serum lipids and C-reactive protein. The left ventricle was dissected out and weighed and the ratio of its weight to the body weight of the animal was calculated, after which it was processed histologically. Sections were stained with hematoxylin-eosin and picrosirius red, to assess morphological and morphometric changes in the ventricle. In Group S+Lec, the soy lecithin had an antidyslipidemic effect and enhanced the serum levels of HDL. However, in the mice in group HL+Lec, soy lecithin did not prevent dyslipidemia, only increasing the serum level of HDL. These effects in these animals influenced the cardiovascular inflammatory process, reducing the level of serum C-reactive protein and preventing LVH. Soy lecithin could thus be used as a treatment or a low-cost alternative preventative measure against dyslipidemia associated with a non-fat diet. However, soy lecithin increases the serum level of HDL, reducing the risk of LVH even in dyslipidemia associated with a high-fat diet.